Inovio partners with Advaccine to make and sell COVID-19 vaccine in China 8:01 AM

(Reuters) – China’s Advaccine Biopharmaceuticals Suzhou Co Ltd will manufacture and sell Inovio Pharmaceuticals Inc’s COVID-19 vaccine candidate in the country, the companies said on Monday.

Advaccine will have the exclusive right to Inovio’s vaccine candidate, INO-4800, in China.…

This news comes via ChinaPulse.com, which delivers news, data, analysis, and insights on Chinese business, travel, finance, health, military, investment, and technology.